Genotyping pattern among iranian HCV positive patients

Iranian Journal of Public Health

Volumn 39, Issue 2, 2010, Pages 39-44

  Hajia, M ^a,b   Amirzargar, A A ^b,c   Khedmat, H ^d   Shahrokhi, N ^b,e   Farzanehkhah, M ^b   Ghorishi, S M ^b   Biglari, S ^b   Salehinodeh, A R ^f   Sarafnejad, A ^b,f  

^a Molecular Research Lab   (Iran)

^b Noor Clinical Laboratory   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e PASTEUR INSTITUTE OF IRAN   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

HCV genotype; Iran; PCR; Viral load

Indexed keywords

EID: 77954078004     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Zali MR, Mayumi M, Raoufi M, Nowroozi A (2000). Hepatitis C virus genotypes in the Islamic Republic of Iran: a preliminary study. East Mediterr Health J, 6(2-3): 372-77.
2. Zein NN. Clinical significance if hepatitis C virus genotypes (2000). Clinical Microbiology Review, 12: 223-35.
3. Agha S, Tanaka Y, Saudy N, Kurbanov F, Abo-Zeid M, EL-Malky M, Khalaf M, Ohta N, Yoshizawa H, Mizokamil M (2004). Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan. J Med Virol, 73(2): 216-22.
4. Nousbaum JB (1998). Genomic subtypes of hepatitis C virus: epidemiology, diagnosis and clinical consequences. Bull Soc Pathol Exot, 91(1):29-33. [Article in French]
5. Matera G, Lamberti A, Quirino A, Focá D, Giancotti A, Barreca GS, Guadagnino V, Liberto MC (2002). Changes in the prevalence of hepatitis C virus (HCV) genotype 4 in Calabria, Southern Italy. Diagn Microbiol Infect Dis, 42(3): 169-73.
6. Abdo AA, Lee SS (2004). Management of hepatitis C virus genotype 4. J Gastroenterol Hepatol, 19(11):1233-39.
7. Campiotto S, Pinho JR, Carrilho FJ, Da Silva C, Souto FJD, Spinelli V, et al. (2005). Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res, 38(1): 41-9.
8. Payan C, Roudot-Thoraval F, Marcellin P, et al. (2007). Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP Geno CII Study. J ViralHepat, 12(4):405-13.
9. Echevarria JM, Leon P, Pozo F, Avellón A (2006). Follow-up of the prevalence of hepatitis C virus genotypes in Spain during a nine-year period (1996-2004). Enferm InfeccMicrobiol Clin, 24(1):20-5.
10. Harris KA, Gilham C, Mortimer PP, Teo CG (1999). The most prevalent hepatitis C virus genotypes in England and Wales are 3a and 1a. J Med Virol, 58(2):127-31.
11. Samimi-Rad K, Nategh R, Malekzadeh R, Norder H, Magnius L (2004). Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol, 74(2): 246-52.
12. Sammi-Rad K, Shahbaz B (2007). Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran. Haemophilia, 13(2): 156-63.
13. Franciscus A (2006). HCV Treatment: predictors of Treatment Response. Hepatitis C Support Project. www.hcvadvocate.org.
14. Hajia M, Shahrokhi N, Amirzargar AA, Farzanehkhah M, Biglari S, Ghorishy M, Sarafnejad A (2007). Prevalence of Hepatitis C virus among Out-Patients of a Private Laboratory in Tehran. Iranian J PublHealth, 36(1):79-84.
15. Gushchin AE, Hoskova OM, Shipulin GA (2003). Development of Amplisens-HCV-genotype reagent set for identification of hepatitis C virus genotypes 1a, 1b, 2a and 3a. Vopr Virusol, 48(3): 45-8. [Article in Russian]
16. Martinot-Peignoux M, Boyer N, Le Breton V, Le Guludec G, Castelnau C, Akremi R, Marcellin P (2000). A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C. Hepatology, 31(3): 788-89.
17. Di Martino V, Lebray P, Myers RP, Pannier E, Paradis V, Charlotte F, Moussalli J, Thabut D, Buffet C, Poynard T (2004). Progressionof liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology, 40(6): 1426-33.